Lymphoma in HIV 1-infected children;Lymphomes chez l'enfant infecte par le VIH-1

Archives de Pediatrie

Volumn 7, Issue 7, 2000, Pages 738-744

  Gandemer, V ^a,c   Verkarre, V ^b   Quartier, P ^a   Brousse, N ^b   Blanche, S ^a  

^a Service d'Immunologie et Hématologie Pédiatrique   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Antineoplastic agents, combined; Child; HIV 1; Lymphoma, AIDS related

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; NAVELBINE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; SURVIVAL TIME; VIRUS LOAD;

EID: 0034234740     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(00)80154-2     Document Type: Article

References (18)

1. 1 Smith S, Lilly S, Mann K, Livingston E, Myers S, Lyerly H, et al. AIDS-related malignancies. Ann Med 1998; 30: 323-44.
2. 2 Granovsky M, Mueller B, Nicholson S, Rosenberg P, Rabkin S. Cancer in HIV-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol 1998; 16: 1729-35.
3. 3 Centers for Disease Control and Prevention: US HIV and AIDS cases reported through December 1996. HIV/AIDS Surveill Rep 1996; 8: 1-39.
4. 4 Patte C, Philip T, Rodary C, Zucker JM, Behrendt H, Gentet JC, et al. High survival rate in advanced stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy. Results of a randomized trial from the French Pediatric Oncology Society on 216 children. J Clin Oncol 1991; 9: 123-32.
5. 5 Evans J, Gibb D, Holland F, Tookey P, Pritchard J, Ades A. Malignancies in UK children with HIV infection acquired from mother to child transmission. Arch Dis Child 1997; 76: 330-3.
6. 6 Nadal D, Caduff R, Frey E, Hassam S, Zimmermann D, Seigneurin J-M, et al. Non-Hodgkin's lymphoma in four children infected with the HIV. Association with EBV and treatment. Cancer 1994; 73: 224-30.
7. 7 Mikol J, Costagliona D, Polivka M, Thiebaut JB, Trotot P. Épidémiologie des lymphomes cérébraux dans le sida. J Neuroradiol 1995; 22: 204-6.
8. 8 Neumann Y, Toren A, Mandel M, Martinowitz V, Varond D, Ramot B, et al. Favorable response of pediatric AIDS-related Burkitt's lymphoma treated by aggressive chemotherapy. Med Pediatr Oncol 1993; 21: 661-6.
9. 9 McClain K, Joshi V, Murphy S. Cancers in children with HIV infection. Hematol/Oncol Clin North Am 1996; 10: 1189-201.
10. 10 Kaplan L, Straus D, Testa M, von Roenn J, Dezube B, Cooley T, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with HIV. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336: 1641-8.
11. 11 Fridrik M, Geit M, Wahl G, Ehrengruber A, Simma R, Hopfel I, et al. Chemotherapy in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphoma. Wien Klin Wochenschr 1998; 110: 15-9.
12. 12 Sparano J, Wiernik P, Hu X, Sana C, Schwartz E, Soeiro R, et al. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanoside and filgrastim in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 3026-35.
13. 13 Davis A, Goldstein D, Milliken S. Long term follow-up of CEOP on the treatment of HIV related non-Hodgkin's lymphoma. Aust N Z J Med 1998; 28: 28-32.
14. 14 Gabarre J, Leblond V, Sutton L, Azar N, Jouan M, Boccacccio C, et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant 1996; 18: 1195-7.
15. 15 Zanussi S, Simonelli C, D'Andrea M, Comar M, Bidoli E, Giacca M, et al. The effects of antineoplastic chemotherapy on HIV disease. AIDS Res Hum Retroviruses 1996; 12: 1703-7.
16. 16 Mc Laughlin P, Grillo-Lopez A, Link B, Levy R, Czuczman M, Williams M, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half respond to a four-dose treatment program. J Clin Oncol 1998; 16: 2825-33.
17. 17 Benkerrou M, Jais JP, Leblond V, Durandy A, Sutton L, Bordigoni P, et al. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: pronostic factors and long-term outcome. Blood 1998; 92: 3137-47.
18. 18 Levy Y, Capitant C, Houhou S, Carriere I, Viard JP, Goujard C, et al. Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS048 study group. Lancet 1999; 353: 1923-9.